Trial Profile
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary) ; Azelaic acid
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Galderma Research & Development
- 10 Feb 2014 New trial record